SA¹ú¼Ê´«Ã½

Tuesday 22 October 2024
Salisbury Foundation Trust

FOI_7165

Internal Reference Number: FOI_7165

Date Request Received: 03/05/2023 00:00:00

Date Request Replied To: 26/05/2023 00:00:00

This response was sent via: By Email

Request Summary: Biologic medicines in Dermatology

Request Category: Researcher

 
Question Number 1:
How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:

• Adalimumab - Humira

• Adalimumab Biosimilar

• Apremilast

• Bimekizumab

• Brodalumab

• Certolizumab

• Deucravacitinib

• Dimethyl fumarate

• Etanercept - Enbrel

• Etanercept Biosimilar

• Guselkumab

• Infliximab - Remicade

• Infliximab Biosimilar

• Ixekizumab

• Risankizumab

• Secukinumab

• Tildrakizumab

• Ustekinumab
 
Answer To Question 1:
• Adalimumab – Humira <5
• Adalimumab Biosimilar 25
• Apremilast <5
• Bimekizumab 0
• Brodalumab <5
• Certolizumab <5
• Deucravacitinib 0
• Dimethyl fumarate 0
• Etanercept – Enbrel 0
• Etanercept Biosimilar 0
• Guselkumab 20
• Infliximab – Remicade 0
• Infliximab Biosimilar 0
• Ixekizumab 5
• Risankizumab <5
• Secukinumab <5
• Tildrakizumab 5
• Ustekinumab 16
 
Question Number 2:
How many patients were treated in the last 3 months by the Dermatology department for Hidradenitis Suppurativa (HS) ONLY with the following biologic drugs:

• Adalimumab - Humira

• Adalimumab Biosimilar

• Infliximab - Remicade

• Infliximab Biosimilar

• Secukinumab

• Ustekinumab
 
Answer To Question 2:
Adalimumab biosimilar - <5

The rest are 0
 
Question Number 3:
How many patients were treated in the last 3 months by the Dermatology department for Psoriasis ONLY in the last three months with the following:

• Ciclosporin

• Methotrexate - any form and strength

• Methotrexate injections 15mg and above
 
Answer To Question 3:
Ciclosporin 8
Methotrexate 18
Methotrexate 15mg and above 0
 
To return to the list of all the FOI requests please click here

Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA¹ú¼Ê´«Ã½, SA¹ú¼Ê´«Ã½ Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 SA¹ú¼Ê´«Ã½
Trust Values